The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as monkeypox) in lesion swab specimens from individuals whose health care provider suspects they have the virus. Only laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 to perform high or moderate complexity tests may perform the test. For more, see the fact sheet for health care providers.

In other news, FDA last week released an update on medical device reports associated with certain Philips Respironics ventilators, BiPAP machines, and CPAP machines recalled in June 2021, which include 346 deaths reportedly associated with the breakdown or suspected breakdown of polyester-based polyurethane foam used in the devices.

Related News Articles

Headline
This season’s flu vaccines for the Southern Hemisphere have reduced the risk of being hospitalized for flu by 52%, based on mid-season data from five countries…
Headline
The Centers for Disease Control and Prevention alerted clinicians, laboratories and public health departments to recent fatal infections from Vibrio…
Headline
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use…
Chairperson's File
It’s been about 65 years since an effective vaccine was first used worldwide against poliomyelitis, or polio. Until then, polio was responsible for about 500,…
Headline
AHA this week released a resource on strategies and tactics that hospitals and health systems can adopt to prevent and control health care-associated…
Headline
The Centers for Disease Control and Prevention is investigating four locally acquired malaria cases in Florida and one in Texas, the first locally…